Pseudotumor cerebri syndrome in children: Clinical characteristic and re-classification.
Children
Freidman criteria
Headache
Idiopathic intracranial hypertension
Jordan
Papilledema
Pseudotumor cerebri
Journal
Brain & development
ISSN: 1872-7131
Titre abrégé: Brain Dev
Pays: Netherlands
ID NLM: 7909235
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
14
01
2022
revised:
14
03
2022
accepted:
22
03
2022
pubmed:
9
4
2022
medline:
1
6
2022
entrez:
8
4
2022
Statut:
ppublish
Résumé
To describe the clinical characteristics of children with pseudotumor cerebri syndrome (PTCS) who were diagnosed according to the modified Dandy criteria and to reclassify them according to the newly proposed diagnostic criteria by Freidman. This retrospective study included the period from January 2016-to July 2021. 50 patients were included; 34 males and 16 females with a male to female ratio of 2.1:1. The average age at onset of symptoms was 8 years. Obesity was noticed in 6 (12%) patients; 34 (68%) had symptoms upon presentation. The most common presenting symptom was headache (28 patients; 56%), papilledema was present in 33 (66%) patients. Most patients (37; 74%) had an initial cerebrospinal fluid (CSF) pressure ≥280 mmH PTCS is a chronic condition. Managing patients who do not have papilledema or who do not meet the newly proposed higher CSF pressure is challenging. Although, applying the newly proposed criteria captured most of our patients, however, around one quarter were managed based on clinical experience. This study indicates a strong need for future guidelines tailored specifically for children, taking into consideration that the cut-off point of CSF pressure might not be similar for all populations.
Identifiants
pubmed: 35393129
pii: S0387-7604(22)00053-5
doi: 10.1016/j.braindev.2022.03.006
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
446-453Informations de copyright
Copyright © 2022 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.